HILLARY BORSA: Open Payments
NPI 1316323793 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,072 in 67 payments from 26 companies in 2025. Trend: 2023 $800 · 2024 $1,538 · 2025 $2,072
Food & beverage: $2,072
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $287 |
| Novo Nordisk Inc | 10 | $200 |
| Sage Therapeutics, LLC | 4 | $174 |
| Daiichi Sankyo Inc. | 1 | $108 |
| Teva Pharmaceuticals USA, Inc. | 1 | $103 |
| Amgen Inc. | 1 | $102 |
| Inspire Medical Systems, Inc. | 3 | $97 |
| Phathom Pharmaceuticals, Inc. | 1 | $97 |
| ABBVIE INC. | 5 | $85 |
| GlaxoSmithKline, LLC. | 4 | $84 |
Products named: AIRSUPRA, FARXIGA, INJECTAFER, AUSTEDO XR, KRYSTEXXA, Wegovy, INSPIRE, VOQUEZNA.
Industry payments across MD — which companies pay providers there.
